Literature DB >> 6693130

Compound heterozygotes in hyperphenylalaninaemia.

K Bartholomé, K Olek, F Trefz.   

Abstract

Three children with hyperphenylalaninaemia and hyperphenylalaninaemic mothers are presented. At least one of the affected children was a compound heterozygote for hyperphenylalaninaemia and phenylketonuria. The families were examined by an L-phenylalanine loading test, by direct determination of phenylalanine hydroxylase and/or a loading test with hepta-deuterophenylalanine. We conclude that most of the patients with moderately elevated serum phenylalanine should have the genotype hyperphenylalaninaemia/phenylketonuria, i.e. they are compound heterozygotes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6693130     DOI: 10.1007/bf00291569

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  5 in total

Review 1.  Phenylketonuria and its variations. A review of recent developments.

Authors:  M E Blaskovics; T L Nelson
Journal:  Calif Med       Date:  1971-07

2.  In vivo residual activities of the phenylalanine hydroxylating system in phenylketonuria and variants.

Authors:  F K Trefz; K Bartholomé; H Bickel; P Lutz; H Schmidt; H W Seyberth
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

3.  Determination of phenylalanine hydroxylase activity in patients with phenylketonuria and hyperphenylalaninemia.

Authors:  K Bartholomé; P Lutz; H Bickel
Journal:  Pediatr Res       Date:  1975-12       Impact factor: 3.756

4.  Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies.

Authors:  R R Lenke; H L Levy
Journal:  N Engl J Med       Date:  1980-11-20       Impact factor: 91.245

5.  Sensitive in vivo assay of the phenylalanine hydroxylating system with a small intravenous dose of heptadeutero L-phenylalanine using high pressure liquid chromatography and capillary gas chromatography/mass fragmentography.

Authors:  F K Trefz; T Erlenmaier; D H Hunneman; K Bartholomé; P Lutz
Journal:  Clin Chim Acta       Date:  1979-12-17       Impact factor: 3.786

  5 in total
  6 in total

1.  Clinical and molecular heterogeneity of phenylalanine hydroxylase deficiencies in France.

Authors:  F Rey; M Berthelon; C Caillaud; S Lyonnet; V Abadie; F Blandin-Savoja; J Feingold; J M Saudubray; J Frézal; A Munnich
Journal:  Am J Hum Genet       Date:  1988-12       Impact factor: 11.025

Review 2.  Atypical cases of phenylketonuria.

Authors:  J L Dhondt; J P Farriaux
Journal:  Eur J Pediatr       Date:  1987       Impact factor: 3.183

3.  DNA haplotype analyses of patients with hyperphenylalaninemia.

Authors:  D Di Silvestre; A Pandya; R Koch; J Groffen
Journal:  Am J Hum Genet       Date:  1990-10       Impact factor: 11.025

4.  Direct detection of a major mutation responsible for phenylketonuria in the population of the Federal Republic of Germany.

Authors:  U Lichter-Konecki; M Schlotter; F K Trefz; D S Konecki
Journal:  Eur J Pediatr       Date:  1989-11       Impact factor: 3.183

Review 5.  Clinical application of genotypic diagnosis for phenylketonuria: theoretical considerations.

Authors:  F D Ledley
Journal:  Eur J Pediatr       Date:  1991-09       Impact factor: 3.183

6.  Compound heterozygosity in nonphenylketonuria hyperphenylalanemia: the contribution of mutations for classical phenylketonuria.

Authors:  S Avigad; S Kleiman; M Weinstein; B E Cohen; G Schwartz; S L Woo; Y Shiloh
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.